Epithelial-mesenchymal transition in development and cancer
- PMID: 19852726
- DOI: 10.2217/fon.09.94
Epithelial-mesenchymal transition in development and cancer
Abstract
The epithelial-mesenchymal transition (EMT) is a critical developmental process from the earliest events of embryogenesis to later morphogenesis and organ formation. EMT contributes to the complex architecture of the embryo by permitting the progression of embryogenesis from a simple single-cell layer epithelium to a complex three-dimensional organism composed of both epithelial and mesenchymal cells. However, in most tissues EMT is a developmentally restricted process and fully differentiated epithelia typically maintain their epithelial phenotype. Recently, elements of EMT, specifically the loss of epithelial markers and the gain of mesenchymal markers, have been observed in pathological states, including epithelial cancers. Analysis of the molecular mechanisms of this oncogenic epithelial plasticity have implicated the inappropriate expression and activation of developmental EMT programs, suggesting that cancer cells may reinstitute properties of developmental EMT including enhanced migration and invasion. Thus, in the context of cancer, an EMT-like process may permit dissemination of tumor cells from the primary tumor into the surrounding stroma, setting the stage for metastatic spread. Consistent with this hypothesis, activation of these developmental EMT programs in human cancer correlates with advanced disease and poor prognosis. This review will focus on the current knowledge regarding developmental EMT pathways that have been implicated in cancer progression.
Similar articles
-
[Epithelial-mesenchymal transitions in cancer onset and progression].Bull Acad Natl Med. 2009 Dec;193(9):1969-78; discussion 1978-9. Bull Acad Natl Med. 2009. PMID: 20666011 French.
-
Molecular signature and therapeutic perspective of the epithelial-to-mesenchymal transitions in epithelial cancers.Drug Resist Updat. 2008 Aug-Oct;11(4-5):123-51. doi: 10.1016/j.drup.2008.07.001. Epub 2008 Aug 20. Drug Resist Updat. 2008. PMID: 18718806 Review.
-
[Epithelial-mesenchymal transition in cancer progression].Postepy Biochem. 2009;55(2):121-8. Postepy Biochem. 2009. PMID: 19824467 Review. Polish.
-
Epithelial-mesenchymal transition in ovarian cancer progression: a crucial role for the endothelin axis.Cells Tissues Organs. 2007;185(1-3):85-94. doi: 10.1159/000101307. Cells Tissues Organs. 2007. PMID: 17587812 Review.
-
Epithelial-mesenchymal transition and its role in the pathogenesis of colorectal cancer.Asian Pac J Cancer Prev. 2013;14(5):2689-98. doi: 10.7314/apjcp.2013.14.5.2689. Asian Pac J Cancer Prev. 2013. PMID: 23803016 Review.
Cited by
-
p19Arf represses platelet-derived growth factor receptor β by transcriptional and posttranscriptional mechanisms.Mol Cell Biol. 2012 Nov;32(21):4270-82. doi: 10.1128/MCB.06424-11. Epub 2012 Aug 20. Mol Cell Biol. 2012. PMID: 22907756 Free PMC article.
-
Protein tyrosine phosphatase receptor-type δ acts as a negative regulator suppressing breast cancer.Oncotarget. 2017 Oct 24;8(58):98798-98811. doi: 10.18632/oncotarget.22000. eCollection 2017 Nov 17. Oncotarget. 2017. PMID: 29228728 Free PMC article.
-
Targeting Pivotal Hallmarks of Cancer for Enhanced Therapeutic Strategies in Triple-Negative Breast Cancer Treatment-In Vitro, In Vivo and Clinical Trials Literature Review.Cancers (Basel). 2024 Apr 12;16(8):1483. doi: 10.3390/cancers16081483. Cancers (Basel). 2024. PMID: 38672570 Free PMC article. Review.
-
Expression of Six1 in luminal breast cancers predicts poor prognosis and promotes increases in tumor initiating cells by activation of extracellular signal-regulated kinase and transforming growth factor-beta signaling pathways.Breast Cancer Res. 2012 Jul 5;14(4):R100. doi: 10.1186/bcr3219. Breast Cancer Res. 2012. PMID: 22765220 Free PMC article.
-
WDR5 inhibition halts metastasis dissemination by repressing the mesenchymal phenotype of breast cancer cells.Breast Cancer Res. 2019 Nov 21;21(1):123. doi: 10.1186/s13058-019-1216-y. Breast Cancer Res. 2019. PMID: 31752957 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources